Cystic fibrosis is inherited in an autosomal recessive pattern, meaning a child must receive a faulty copy of the CFTR gene from both parents to develop the disease. A child who inherits only one faulty copy becomes a carrier, showing no symptoms but able to pass the gene to their own children. The gene sits on chromosome 7, so it has nothing to do with sex chromosomes, and boys and girls are equally likely to be affected.
What the CFTR Gene Does
The CFTR gene provides instructions for building a channel protein that moves chloride ions (a component of salt) across the surface of cells lining the lungs, pancreas, sweat glands, and digestive tract. This chloride flow controls the water content of mucus and other secretions. When the gene is working normally, those secretions stay thin and slippery.
When both copies of the gene are faulty, the chloride channel either doesn’t form, doesn’t reach the cell surface, or doesn’t open properly. Without normal chloride transport, water can’t follow, and the mucus that coats these organs becomes thick and sticky. That buildup is what drives the lung infections, digestive problems, and other complications associated with cystic fibrosis.
The Math Behind Inheritance
When both parents carry one normal and one mutated copy of the CFTR gene, each pregnancy has the following odds, as outlined by the National Heart, Lung, and Blood Institute:
- 25% chance the child inherits two normal copies and is completely unaffected.
- 50% chance the child inherits one normal copy and one mutated copy, becoming a carrier with no symptoms.
- 25% chance the child inherits two mutated copies and has cystic fibrosis.
These odds reset with every pregnancy. Having one child with CF doesn’t change the probability for the next. And because carriers are completely healthy, many couples have no idea they carry the gene until a child is diagnosed.
If only one parent is a carrier and the other has two normal copies, none of their children will have CF. Half will be carriers, and half will have no mutated gene at all. If one parent actually has CF (two mutated copies) and the other is not a carrier, every child will be a carrier, but none will have the disease.
How Common Are Carriers?
Carrier rates vary by ethnic background. Among people of Northern European descent, roughly 1 in 27 are carriers. For Hispanic Americans, the rate is approximately 1 in 48. Among African Americans, it’s about 1 in 79. Asian American populations have lower carrier rates still. Because carriers are symptom-free, most never know their status unless they pursue genetic testing.
The F508del Mutation and Why Mutations Vary
More than 2,000 mutations in the CFTR gene have been identified, but one dominates. A mutation called F508del accounts for about 80% of CF cases. Roughly 40 to 50% of people with CF carry two copies of F508del. This mutation causes the chloride channel protein to misfold, so the cell’s quality-control system destroys it before it ever reaches the surface.
Not all mutations do the same thing. Some prevent the protein from being made at all. Others allow the protein to reach the cell surface but keep the channel locked shut. Still others let the channel open but reduce how much chloride flows through. The specific combination of mutations a person carries influences how severe their symptoms are, which organs are most affected, and which newer therapies may work for them.
A person can inherit two copies of the same mutation (homozygous) or two different mutations, one from each parent (compound heterozygous). Compound heterozygotes are common, and the pairing of mutations matters. Someone carrying one severe and one milder mutation may have less aggressive disease than someone with two severe mutations.
How CF Is Detected
In the United States, every newborn is screened for cystic fibrosis through a heel-prick blood test. The test measures a substance called immunoreactive trypsinogen, or IRT, which is elevated in babies with CF because of early pancreatic inflammation. If IRT is high, the same blood sample is checked for common CFTR gene mutations. Babies with elevated IRT and at least one identified mutation are referred for a confirmatory sweat test.
The sweat test measures the concentration of chloride in sweat. People with CF have saltier sweat because their faulty chloride channels can’t reabsorb salt in sweat glands. A chloride level above 60 mmol/L confirms the diagnosis. Below 40 mmol/L rules it out. Results between 40 and 60 fall into a borderline range that requires repeat testing or additional genetic analysis.
Carrier Screening Before and During Pregnancy
Since 2005, the American College of Obstetricians and Gynecologists has recommended offering cystic fibrosis carrier screening to all patients, ideally before pregnancy. The test is a simple blood draw or saliva sample that checks for the most common CFTR mutations.
If one partner tests positive as a carrier, the other partner should be tested. If both are carriers, genetic counseling can walk through the 1-in-4 risk per pregnancy and lay out options. Those options include conceiving naturally and testing the pregnancy through amniocentesis or chorionic villus sampling, using IVF with preimplantation genetic testing to select embryos without two faulty copies, using donor eggs or sperm, or adoption. CF is one of the most common reasons couples pursue preimplantation genetic testing during IVF.
Because carrier status runs in families, a person who tests positive is encouraged to let siblings, cousins, and other relatives know so they can get screened too. Your doctor won’t share your results with family members without your permission, so that conversation is yours to have.
Why Some Families Have No Warning
The autosomal recessive pattern is precisely why CF can seem to appear “out of nowhere.” Carriers are completely healthy. The mutated gene can pass silently through multiple generations without ever producing a child with CF, because it takes two carriers partnering together for the disease to surface. Even then, three out of four pregnancies will produce a child without the condition. A family can carry the gene for decades and never know it until two carriers happen to have a child who inherits both copies.